Skip to main content

Table 3 Parameters related to AAV activity within the kidneys depending on the severity of the disease

From: Assessment of the correlation of commonly used laboratory tests with clinical activity, renal involvement and treatment of systemic small-vessel vasculitis with the presence of ANCA antibodies

Disease form

Creatinine (mg/dl)

GFR(ml/min/1.73 m²)

Urea(mg/dl)

Proteinuria (g/24 h)

Hematuria

localized and early systemic n = 6

0,9(0,775;3,15)

90(39,75;90,0)

40 (33,75;67,25)

0,154(0,04;0,62)

0.0(0,0;3)

generalized n = 10

2,4(1,62;3,1)

26,5(15,5;47,5)

77 (50,0;97,9)

0,88(0,4;1,98)

3 (2,5;3,0)

severe n = 12

5,35(4,67;6,37)

9,5(7,25;12,0)

174,5(88,5;198,5)

0,85(0,42;1,2)

3 (2,0;3,0)

P *

0,002

0,002

0,002

0,047

0,077

P**

0,000

0,000

0,000

0,064

0,147

  1. Values are median (IQR)
  2. P * in the Kruskal-Wallis test. P** in the Jonckheere-Terpstra test for the trend